Kirk, A., Guasch, A., Xu, H., Cheeseman, J., Mead, S., Ghali, A., … Pearson, T. (2014). Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. In Transplantation (Vol. 98, pp. 80–80). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/00007890-201407151-00248

Kirk, A., A. Guasch, H. Xu, J. Cheeseman, S. Mead, A. Ghali, A. Mehta, et al. “Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept.” In Transplantation, 98:80–80. Ovid Technologies (Wolters Kluwer Health), 2014. https://doi.org/10.1097/00007890-201407151-00248.

Kirk A, Guasch A, Xu H, Cheeseman J, Mead S, Ghali A, et al. Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. In: Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 80–80.

Kirk, A., et al. “Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept.” Transplantation, vol. 98, Ovid Technologies (Wolters Kluwer Health), 2014, pp. 80–80. Crossref, doi:10.1097/00007890-201407151-00248.

Kirk A, Guasch A, Xu H, Cheeseman J, Mead S, Ghali A, Mehta A, Gebel H, Bray R, Horan J, Kean L, Larsen C, Pearson T. Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. Transplantation. Ovid Technologies (Wolters Kluwer Health); 2014. p. 80–80.